(1R,5S)-N,N-dimethyl-3-(8-pyrazol-1-yl-6H-isochromeno[3,4-b]pyridin-3-yl)-3-azabicyclo[3.1.0]hexan-6-amine
C22H23N5O — CID 156844606
Data last refreshed: (MolForge compound catalog, from PubChem)
About (1R,5S)-N,N-dimethyl-3-(8-pyrazol-1-yl-6H-isochromeno[3,4-b]pyridin-3-yl)-3-azabicyclo[3.1.0]hexan-6-amine
(1R,5S)-N,N-dimethyl-3-(8-pyrazol-1-yl-6H-isochromeno[3,4-b]pyridin-3-yl)-3-azabicyclo[3.1.0]hexan-6-amine (PubChem CID 156844606) has the molecular formula C22H23N5O and a molecular weight of 373.46 g/mol. Its IUPAC name is (1R,5S)-N,N-dimethyl-3-(8-pyrazol-1-yl-6H-isochromeno[3,4-b]pyridin-3-yl)-3-azabicyclo[3.1.0]hexan-6-amine.
Molecular Properties
| Compound Name | (1R,5S)-N,N-dimethyl-3-(8-pyrazol-1-yl-6H-isochromeno[3,4-b]pyridin-3-yl)-3-azabicyclo[3.1.0]hexan-6-amine |
|---|---|
| PubChem CID | 156844606 |
| Molecular Formula | C22H23N5O |
| Molecular Weight | 373.46 g/mol |
| Exact Mass | 373.19 |
| IUPAC Name | (1R,5S)-N,N-dimethyl-3-(8-pyrazol-1-yl-6H-isochromeno[3,4-b]pyridin-3-yl)-3-azabicyclo[3.1.0]hexan-6-amine |
| SMILES | CN(C)C1[C@H]2CN(c3ccc4c(n3)OCc3cc(-n5cccn5)ccc3-4)C[C@@H]12 |
| InChI | InChI=1S/C22H23N5O/c1-25(2)21-18-11-26(12-19(18)21)20-7-6-17-16-5-4-15(27-9-3-8-23-27)10-14(16)13-28-22(17)24-20/h3-10,18-19,21H,11-13H2,1-2H3/t18-,19+,21? |
| InChIKey | SNZQNMRDQKXGBK-PMSBKCLSSA-N |
| XLogP | 2.82 |
| TPSA | 46.42 Ų |
| H-Bond Donors | |
| H-Bond Acceptors | 6 |
| Rotatable Bonds | 3 |
| Heavy Atoms | 28 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 373.46 |
| LogP ≤ 5 | 2.82 |
| H-Bond Donors ≤ 5 | 0 |
| H-Bond Acceptors ≤ 10 | 6 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 156844606 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.